Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas

by Muenst, S., Hoeller, S., Willi, N., Dirnhofer, S., Tzankov, A.
Published 2010

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38...

by Tzankov, Alexandar, Leu, Nora, Muenst, Simone, Juskevicius, Darius, Klingbiel, Dirk, Mamot, Christoph, Dirnhofer, Stephan
Published 2015

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer

by Soysal, S D, Muenst, S, Barbie, T, Fleming, T, Gao, F, Spizzo, G, Oertli, D, Viehl, C T, Obermann, E C, Gillanders, W E
Published 2013

Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies

by Ramachandran, Sarada D, Vivarès, Aurélie, Klieber, Sylvie, Hewitt, Nicola J, Muenst, Bernhard, Heinz, Stefan, Walles, Heike, Braspenning, Joris
Published 2015

Nuclear Expression of Snail Is an Independent Negative Prognostic Factor in Human Breast Cancer

by Muenst, S., Däster, S., Obermann, E. C., Droeser, R. A., Weber, W. P., von Holzen, U., Gao, F., Viehl, C., Oertli, D., Soysal, S. D.
Published 2013